다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Evidence-based Complementary and Alternative Medicine : eCAM, v.2018, 2018년, pp.7421489 -
Ożarowski, Marcin (Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego 71b, 60-630 Poznań) , Mikołajczak, Przemysław Ł. (, Poland) , Kujawski, Radosław (Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego 71b, 60-630 Poznań) , Wielgus, Karolina (, Poland) , Klejewski, Andrzej (Department of Pharmacology, Poznań) , Wolski, Hubert (University of Medical Sciences, Rokietnicka, 5a, 60-806 Poznań) , Seremak-Mrozikiewicz, Agnieszka (, Poland)
AI-Helper
Since improving maternal and child health is a public health priority worldwide, the main aim of treatment of hypertension in pregnant women is to prevent complications during pregnancy, labor, and postpartum. In consequence, much attention is paid to the use of antihypertensive drugs that can be us...
1 Townsend R. O’Brien P. Khalil A. Current best practice in the management of hypertensive disorders in pregnancy Integrated Blood Pressure Control 2016 9 79 94 2-s2.0-84992410728 10.2147/IBPC.S77344 27555797
2 Mammaro A. Carrara S. Cavaliere A. Hypertensive Disorders of Pregnancy Journal of Prenatal Medicine 2009 3 1 1 5 22439030
3 Pre-eclampsia 2018/19 ICD-10-CM Codes, at: https://www.icd10data.com/ICD10CM/Codes/O00-O9A/O10-O16/O14
4 Luanni V. B. Ota E. Togoobaatar G. Rintaro M. João P. S. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middleIncome countries: a WHO secondary analysis PLoS ONE 2014 9 3 p. e91198 24657964
5 Fauci A. S. Braunwald E. Kasper D. L. Fauci A. S. Braunwald E. Kasper D. L. Disorders of intermediary metabolism Harrison’s Principles of Internal Medicine 2008 17th New York, NY, USA McGraw-Hill 2426 2429 10.1111/j.1445-5994.2008.01837.x
6 Masoura S. Kalogiannidis I. A. Gitas G. Biomarkers in pre-eclampsia: A novel approach to early detection of the disease Journal of Obstetrics & Gynaecology 2012 32 7 609 616 2-s2.0-84866147053 10.3109/01443615.2012.709290 22943702
7 Myatt L. Roberts J. M. Preeclampsia: Syndrome or Disease? Current Hypertension Reports 2015 17 11, article no. 83 2-s2.0-84941957980 10.1007/s11906-015-0595-4 26362531
8 Rehfeldt M. Eklund E. Struck J. Relaxin-2 connecting peptide (pro-RLX2) levels in second trimester serum samples to predict preeclampsia Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 2018 11 124 128 2-s2.0-85033586546 10.1016/j.preghy.2017.11.001
9 Schaefer C. Peters P. Miller R. K. Drugs during Pregnancy and Lactation. Treatment Options and Risk Assessment 2007 Oxford, UK Elsevier
10 Myatt L. Webster R. P. Is vascular biology in preeclampsia better? Journal of Thrombosis and Haemostasis 2009 7 3 375 384 2-s2.0-59849107288 10.1111/j.1538-7836.2008.03259.x 19087223
11 Middeldorp S. Pregnancy Failure and Heritable Thrombophilia Seminars in Hematology 2007 44 2 93 97 2-s2.0-34047263027 10.1053/j.seminhematol.2007.01.005 17433901
12 Baumwell S. Karumanchi S. A. Pre-eclampsia: clinical manifestations and molecular mechanisms Nephron Clinical Practice 2007 106 2 c72 c81 10.1159/000101801 2-s2.0-34250676880 17570933
13 Fatini C. Sticchi E. Gensini F. Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow Journal of Hypertension 2006 24 9 1823 1829 2-s2.0-33747475254 10.1097/01.hjh.0000242407.58159.87 16915032
14 Napolitano M. Miceli F. Calce A. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas The Journal of Clinical Endocrinology & Metabolism 2000 85 6 2318 2323 2-s2.0-0034455696 10.1210/jc.85.6.2318 10852470
15 Powe C. E. Levine R. J. Karumanchi S. A. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease Circulation 2011 123 24 2856 2869 10.1161/CIRCULATIONAHA.109.853127 2-s2.0-79959507759 21690502
16 Tomimatsu T. Mimura K. Endo M. Kumasawa K. Kimura T. Pathophysiology of preeclampsia: An angiogenic imbalance and long-lasting systemic vascular dysfunction Hypertension Research 2017 40 4 305 310 2-s2.0-85017121022 10.1038/hr.2016.152 27829661
17 Słowiński T. Neumayer H. Stolze T. Gossing G. Halle H. Hocher B. Endothelin system in normal and hypertensive pregnancy Clinical Science 2002 103 s2002 446S 449S 10.1042/CS103S446S 12193142
18 Baksu B. Davas I. Baksu A. Akyol A. Gulbaba G. Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women International Journal of Gynecology and Obstetrics 2005 90 2 112 117 2-s2.0-22144487329 10.1016/j.ijgo.2005.04.018 16005006
19 Amaral L. M. Cunningham M. W. Cornelius D. C. LaMarca B. Preeclampsia: long-term consequences for vascular health Vascular Health and Risk Management 2015 11 403 415 10.2147/VHRM.S64798 2-s2.0-84939785135 26203257
20 Possomato-Vieira J. S. Khalil R. A. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia Advances in Pharmacology 2016 77 361 431 2-s2.0-84994137745 10.1016/bs.apha.2016.04.008 27451103
21 Bakrania B. Duncan J. Warrington J. P. Granger J. P. The endothelin type a receptor as a potential therapeutic target in preeclampsia International Journal of Molecular Sciences 2017 18 3, article 522 1 8 10.3390/ijms18030522 2-s2.0-85014324666
22 Granger J. P. Spradley F. T. Bakrania B. A. The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia Current Hypertension Reports 2018 20 4 10.1007/s11906-018-0828-4
23 Calabró V. Litterio M. C. Fraga C. G. Galleano M. Piotrkowski B. Effects of quercetin on heart nitric oxide metabolism in l -NAME treated rats Archives of Biochemistry and Biophysics 2018 647 47 53 10.1016/j.abb.2018.03.041 29621523
24 Pereira S. C. Parente J. M. Belo V. A. Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension Atherosclerosis 2018 270 146 153 2-s2.0-85041401361 10.1016/j.atherosclerosis.2018.01.031 29425960
25 Ajibade T. O. Oyagbemi A. A. Omobowale T. O. Asenuga E. R. Adigun K. O. Quercetin and Vitamin C Mitigate Cobalt Chloride-Induced Hypertension through Reduction in Oxidative Stress and Nuclear Factor Kappa Beta (NF-Kb) Expression in Experimental Rat Model Biological Trace Element Research 2017 175 2 347 359 2-s2.0-84973660964 10.1007/s12011-016-0773-5 27283837
26 Plotnikov M. B. Aliev O. I. Sidekhmenova A. V. Modes of Hypotensive Action of Dihydroquercetin in Arterial Hypertension Bulletin of Experimental Biology and Medicine 2017 162 3 353 356 2-s2.0-85009477051 10.1007/s10517-017-3614-4 28091909
27 Morales-Cano D. Menendez C. Moreno E. The flavonoid quercetin reverses pulmonary hypertension in rats PLoS ONE 2014 9 12 2-s2.0-84914706350 10.1371/journal.pone.0114492 e114492
28 Galindo P. González-Manzano S. Zarzuelo M. J. Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats Food & Function 2012 3 6 643 650 10.1039/c2fo10268d 2-s2.0-84867864631 22441211
29 Gao H. Chen C. Huang S. Li B. Quercetin attenuates the progression of monocrotaline-induced pulmonary hypertension in rats Journal of Biomedical Research 2012 26 2 98 102 2-s2.0-84859717981 10.1016/S1674-8301(12)60018-9 23554737
30 Monteiro M. M. O. França-Silva M. S. Alves N. F. B. Porpino S. K. P. Braga V. A. Quercetin improves baroreflex sensitivity in spontaneously hypertensive rats Molecules 2012 17 11 12997 13008 2-s2.0-84870231302 10.3390/molecules171112997 23117438
31 Romero M. Jiménez R. Hurtado B. Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats European Journal of Pharmacology 2010 627 1–3 242 250 10.1016/j.ejphar.2009.11.006 2-s2.0-73449145596 19903466
32 Carlstrom J. Symons J. D. Tzu C. W. Bruno R. S. Litwin S. E. Jalili T. A quercetin supplemented diet does not prevent cardiovascular complications in spontaneously hypertensive rats Journal of Nutrition 2007 137 3 628 633 2-s2.0-33947175585 10.1093/jn/137.3.628 17311951
33 Duarte J. Pérez-Palencia R. Vargas F. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats British Journal of Pharmacology 2001 133 1 117 124 10.1038/sj.bjp.0704064 2-s2.0-0034987459 11325801
34 Plotnikov M. B. Aliev O. I. Anishchenko A. M. Sidekhmenova A. B. Shamanaev A. Y. Fomina T. I. Parameters of cerebral cortex capillary network in SHR rats during the development of arterial hypertension and stable high blood pressure Rossiiskii Fiziologicheskii Zhurnal 2016 102 5 558 566
35 Slashcheva G. A. Rykov V. A. Lobanov A. V. Dihydroquercetin Does Not Affect Age-Dependent Increase in Blood Pressure and Angiotensin-Converting Enzyme Activity in the Aorta of Hypertensive Rats Bulletin of Experimental Biology and Medicine 2016 161 5 670 673 2-s2.0-85028257069 10.1007/s10517-016-3482-3 27709387
36 Brüll V. Burak C. Stoffel-Wagner B. Acute intake of quercetin from onion skin extract does not influence postprandial blood pressure and endothelial function in overweight-to-obese adults with hypertension: a randomized, double-blind, placebo-controlled, crossover trial European Journal of Nutrition 2017 56 3 1347 1357 2-s2.0-84959344856 10.1007/s00394-016-1185-1 26924303
37 Biesinger S. Michaels H. A. Quadros A. S. A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects European Journal of Clinical Nutrition 2016 70 1 10 16 2-s2.0-84953636587 10.1038/ejcn.2015.88 26059745
38 Dower J. I. Geleijnse J. M. Gijsbers L. Zock P. L. Kromhout D. Hollman P. C. H. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial American Journal of Clinical Nutrition 2015 101 5 914 921 10.3945/ajcn.114.098590 2-s2.0-84929657335 25934864
39 Dower J. I. Geleijnse J. M. Gijsbers L. Schalkwijk C. Kromhout D. Hollman P. C. Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial Journal of Nutrition 2015 145 7 1459 1463 10.3945/jn.115.211888 2-s2.0-84935509803 25972527
40 Brüll V. Burak C. Stoffel-Wagner B. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial British Journal of Nutrition 2015 114 8 1263 1277 10.1017/s0007114515002950 2-s2.0-84944171066 26328470
41 Perez A. Gonzalez-Manzano S. Jimenez R. The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: Correlation with beta-glucuronidase activity Pharmacological Research 2014 89 11 18 2-s2.0-84905820086 10.1016/j.phrs.2014.07.005 25076013
42 Larson A. Witman M. A. H. Guo Y. Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: Nitric oxide Nutrition Research 2012 32 8 557 564 2-s2.0-84865567726 10.1016/j.nutres.2012.06.018 22935338
43 Serban M. C. Sahebkar A. Zanchetti A. Lipid and blood pressure meta-analysis collaboration (LBPMC) group. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials Journal of the American Heart Association 2016 5 7 10 1161
44 Draganovic D. Lucic N. Jojic D. Milicevic S. Correlation of oxidative stress markers with ultrasound and cardiotocography parameters with hypertension induced pregnancy Acta Informatica Medica 2017 25 1 19 23 2-s2.0-85018442960 10.5455/aim.2017.25.19-23 28484292
45 Bharadwaj S. Bhat V. B. Vickneswaran V. Adhisivam B. Zachariah B. Habeebullah S. Oxidative stress in preeclamptic mother–newborn dyads and its correlation with early neonatal outcome–a case control study The Journal of Maternal-Fetal and Neonatal Medicine 2018 31 12 1548 1553 2-s2.0-85018429951 10.1080/14767058.2017.1319933 28412854
46 Cornelius D. C. Preeclampsia: From inflammation to immunoregulation Clinical Medicine Insights: Blood Disorders 2018 11 1 6 2-s2.0-85041418349
47 Zhou Y. McMaster M. Woo K. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome The American Journal of Pathology 2002 160 4 1405 1423 10.1016/S0002-9440(10)62567-9 62567 2-s2.0-0036114404 11943725
48 Liberis A. Stanulov G. Chafouz Ali E. Hassan A. Pagalos A. Kontomanolis E. N. Pre-eclampsia and the vascular endothelial growth factor: A new aspect Clinical and Experimental Obstetrics & Gynecology 2016 43 1 9 13 2-s2.0-84960892707 10.12891/ceog2057.2016 27048010
49 Chau K. Hennessy A. Makris A. Placental growth factor and pre-eclampsia Journal of Human Hypertension 2017 31 12 782 786 2-s2.0-85033221572 10.1038/jhh.2017.61 29115294
50 Hentschke M. R. Ruszkowski R. A. da Costa B. E. Poli-de-Figueiredo C. E. Placental growth factor and severity of preeclampsia: biomarkers, prediction of preeclampsia Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 2016 6 3 p. 156
51 Manriquez Rocha B. Mbofana F. Loquiha O. Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 2018 11 26 31 2-s2.0-85043365645 10.1016/j.preghy.2017.12.005
52 Xu B. Nakhla S. Makris A. Hennessy A. TNF- α inhibits trophoblast integration into endothelial cellular networks Placenta 2011 32 3 241 246 2-s2.0-79951946337 10.1016/j.placenta.2010.12.005 21215448
53 Smith S. Francis R. Guilbert L. Baker P. N. Growth factor rescue of cytokine mediated trophoblast apoptosis Placenta 2002 23 4 322 330 2-s2.0-0036547596 10.1053/plac.2001.0783 11969343
54 Marwa B. A. G. Raguema N. Zitouni H. FGF1 and FGF2 mutations in preeclampsia and related features Placenta 2016 43 81 85 2-s2.0-84971322238 10.1016/j.placenta.2016.05.007 27324104
55 Hohlagschwandtner M. Knöfler M. Ploner M. Zeisler H. Joura E. A. Husslein P. Basic fibroblast growth factor and hypertensive disorders in pregnancy Hypertension in Pregnancy 2002 21 3 235 241 2-s2.0-0036951137 10.1081/PRG-120016790 12517330
56 Frampton G. K. Jones J. Rose M. Payne L. Placental growth factor (Alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: Systematic review and economic analysis Health Technology Assessment 2016 20 87 1 192 2-s2.0-85006040020 10.3310/hta20870
57 Duckworth S. Griffin M. Seed P. T. Diagnostic Biomarkers in Women with Suspected Preeclampsia in a Prospective Multicenter Study Obstetrics & Gynecology 2016 128 2 245 252 2-s2.0-84978173363 10.1097/AOG.0000000000001508 27400001
58 Kaluba-Skotarczak A. Magiełda J. Romała A. Importance of polymorphic variants of Tumour Necrosis Factor— α gene in the etiology of Intrauterine Growth Restriction Ginekologia Polska 2018 89 3 160 168 10.5603/GP.a2018.0027 29664552
59 Lowe S. A. Rubin P. C. The pharmacological management of hypertension in pregnancy Journal of Hypertension 1992 10 3 201 207 2-s2.0-0026555778 10.1097/00004872-199203000-00001 1315815
60 Seremak-Mrozikiewicz A. Drews K. Methyldopa in therapy of hypertension in pregnant women Ginekologia Polska 2004 75 2 160 165 2-s2.0-2542504790 15108591
61 Picaud A. Walter P. de Preville G. Nicolas P. Fatal toxic hepatitis in pregnancy. A discuss the role of methyldopa Journal de Gynécologie Obstétrique et Biologie de la Reproduction 1990 19 2 192 161
62 Sibai B. M. Treatment of hypertension in pregnant women The New England Journal of Medicine 1996 335 4 257 265 2-s2.0-0029893242 10.1056/NEJM199607253350407 8657243
63 Caton A. R. Bell E. M. Druschel C. M. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations Hypertension 2009 54 1 63 70 10.1161/HYPERTENSIONAHA.109.129098 2-s2.0-67649866339 19433779
64 Xie R.-H. Guo Y. Krewski D. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population European Journal of Obstetrics & Gynecology and Reproductive Biology 2013 171 2 281 285 2-s2.0-84890433175 10.1016/j.ejogrb.2013.09.032 24139131
65 Adrover R. Hepatotoxicity from Alpha-Methyldopa During Pregnancy: Two Case Reports Journal of Clinical Gastroenterology and Treatment 2016 2 3 10.23937/2469-584X/1510031
66 Aldomet (methyldopa) side effects: https://www.rxlist.com/aldomet-side-effects-drug-center.htm , 2018
67 Ghanem F. A. Movahed A. Use of antihypertensive drugs during pregnancy and lactation Cardiovascular Therapeutics 2008 26 1 38 49 2-s2.0-47049084268 18466419
68 Singh P. Mishra A. Goswami S. Singh A. Tiwari K. D. Hypertension and herbal plant for its treatment: a review Indian Journal of Research in Pharmacy and Biotechnology 2015 3 5 358 366
69 Tomé-Carneiro J. Visioli F. Polyphenol-based nutraceuticals for the prevention and treatment of cardiovascular disease: review of human evidence Phytomedicine 2016 23 11 1145 1174 10.1016/j.phymed.2015.10.018 2-s2.0-84952928413 26776959
70 Schürger N. Klein E. Hapfelmeier A. Kiechle M. Paepke D. Demand for integrative medicine among women in pregnancy and childbed: a German survey on patients’ needs BMC Complementary and Alternative Medicine 2018 18 1 p. 187 10.1186/s12906-018-2249-y
71 Kennedy D. A. Lupattelli A. Koren G. Nordeng H. Herbal medicine use in pregnancy: results of a multinational study BMC Complementary and Alternative Medicine 2013 13 1 1 10 10.1186/1472-6882-13-355 23280361
72 John L. J. Shantakumari N. Herbal medicines use during pregnancy: A review from the middle east Oman Medical Journal 2015 30 4 229 236 2-s2.0-84941551524 10.5001/omj.2015.48 26366255
73 Akour A. Kasabri V. Afifi F. U. Bulatova N. The use of medicinal herbs in gynecological and pregnancy-related disorders by Jordanian women: a review of folkloric practice vs. evidence-based pharmacology Pharmaceutical Biology 2016 54 9 1901 1918 2-s2.0-84959062395 10.3109/13880209.2015.1113994 26911517
74 Mekuria A. B. Erku D. A. Gebresillassie B. M. Birru E. M. Tizazu B. Ahmedin A. Prevalence and associated factors of herbal medicine use among pregnant women on antenatal care follow-up at University of Gondar referral and teaching hospital, Ethiopia: A cross-sectional study BMC Complementary and Alternative Medicine 2017 17 1 2-s2.0-85011268706
75 Dugoua J.-J. Herbal medicines and pregnancy Journal of Population Therapeutics and Clinical Pharmacology 2010 17 3 e370 e378 2-s2.0-84873430091 21041871
76 Bruno L. O. Simoes R. S. de Jesus Simoes M. Girão M. J. B. C. Grundmann O. Pregnancy and herbal medicines: An unnecessary risk for women's health-A narrative review Phytotherapy Research 2018 32 796 810 2-s2.0-85041638125 29417644
77 Mate A. Medicinal and Aromatic Plants of the World. Scientific, Production, Commercial and Utilization Aspects, vol. 1 2015 Dordrecht, Netherlands Springer Science + Business Media
78 Terao J. Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function Biochemical Pharmacology 2017 139 15 23 2-s2.0-85017357323 10.1016/j.bcp.2017.03.021 28377278
79 Romano B. Pagano E. Montanaro V. Fortunato A. L. Milic N. Borrelli F. Novel insights into the pharmacology of flavonoids Phytotherapy Research 2013 27 11 1588 1596 2-s2.0-84886313370 10.1002/ptr.5023 23824931
80 Quiñones M. Miguel M. Aleixandre A. Beneficial effects of polyphenols on cardiovascular disease Pharmacological Research 2013 68 1 125 131 10.1016/j.phrs.2012.10.018 2-s2.0-84872313212 23174266
81 Yamagata K. Tagami M. Yamori Y. Dietary polyphenols regulate endothelial function and prevent cardiovascular disease Nutrition Journal 2015 31 1 28 37 10.1016/j.nut.2014.04.011 2-s2.0-84922260469
82 Alves J. L. D. B. de Sousa V. P. Neto M. P. C. New insights on the use of dietary polyphenols or probiotics for the management of arterial hypertension Frontiers in Physiology 2016 7 448 2-s2.0-84995960765
83 Emerenciano V. Militão J. Campos C. Flavonoids as chemotaxonomic markers for Asteraceae Biochemical Systematics and Ecology 2001 29 9 947 957 10.1016/S0305-1978(01)00033-3 11445295
84 Kumar S. Pandey A. K. Chemistry and Biological Activities of Flavonoids: An Overview The Scientific World Journal 2013 2013 16 162750 10.1155/2013/162750
85 Dixon R. A. Pasinetti G. M. Flavonoids and isoflavonoids: from plant biology to agriculture and neuroscience Plant Physiology 2010 154 2 453 457 10.1104/pp.110.161430 2-s2.0-77957735770 20921162
86 Andersen Ø. M. Markham K. R. Flavonoids Chemistry. Flavonoids. Chemistry, Biochemistry and Applications 2006 Boca Raton, Fla, USA CRC Press, Taylor & Francis Group
87 Dharmashankar K. Widlansky M. E. Vascular endothelial function and hypertension: insights and directions Current Hypertension Reports 2010 12 6 448 455 10.1007/s11906-010-0150-2 2-s2.0-78649905840 20857237
88 Widmer R. J. Lerman A. Endothelial dysfunction and cardiovascular disease Global Cardiology Science Practice 2014 2014 3 291 308 25780786
89 Konukoglu D. Uzun H. Endothelial dysfunction and hypertension Advances in Experimental Medicine and Biology 2016 956 511 540 2-s2.0-85019263176 10.1007/5584_2016_90
90 Rastogi S. Pandey M. M. Rawat A. K. S. Traditional herbs: a remedy for cardiovascular disorders Phytomedicine 2016 23 11 1082 1089 2-s2.0-84949673290 10.1016/j.phymed.2015.10.012 26656228
91 Kim Y. Je Y. Flavonoid intake and mortality from cardiovascular disease and all causes: A meta-analysis of prospective cohort studies Clinical Nutrition ESPEN 2017 20 68 77 2-s2.0-85018174675 10.1016/j.clnesp.2017.03.004 29072172
92 Chirumbolo S. Flavonoids in coronary heart disease Thrombosis Research 2015 135 5 1040 1041 10.1016/j.thromres.2015.03.009 25770596
93 Edwards R. L. Lyon T. Litwin S. E. Rabovsky A. Symons J. D. Jalili T. Quercetin reduces blood pressure in hypertensive subjects Journal of Nutrition 2007 137 11 2405 2411 2-s2.0-35848966547 10.1093/jn/137.11.2405 17951477
94 Bondonno N. P. Bondonno C. P. Hodgson J. M. Ward N. C. Croft K. D. The Efficacy of Quercetin in Cardiovascular Health Current Nutrition Reports 2015 4 4 290 303 10.1007/s13668-015-0137-3
95 Gormaz J. G. Quintremil S. Rodrigo R. Cardiovascular disease: A target for the pharmacological effects of quercetin Current Topics in Medicinal Chemistry 2015 15 17 1735 1742 2-s2.0-84931834215 10.2174/1568026615666150427124357 25915608
96 Todaka E. Sakurai K. Fukata H. Fetal exposure to phytoestrogens - The difference in phytoestrogen status between mother and fetus Environmental Research 2005 99 2 195 203 2-s2.0-23744472139 10.1016/j.envres.2004.11.006 16194669
97 Vanhees K. Godschalk R. W. Sanders A. Van Waalwijk van Doorn-Khosrovani S. B. Van Schooten F. J. Maternal quercetin intake during pregnancy results in an adapted iron homeostasis at adulthood Toxicology 2011 290 2-3 351 359 2-s2.0-84858620311
98 Prater M. R. Laudermilch C. L. Liang C. Holladay S. D. Placental Oxidative Stress Alters Expression of Murine Osteogenic Genes and Impairs Fetal Skeletal Formation Placenta 2008 29 9 802 808 2-s2.0-50249171811 10.1016/j.placenta.2008.06.010 18675455
99 Liang C. Oest M. E. Jones J. C. Prater M. R. Gestational high saturated fat diet alters C57BL/6 mouse perinatal skeletal formation Birth Defects Research Part B - Developmental and Reproductive Toxicology 2009 86 5 362 369 2-s2.0-70350732826 10.1002/bdrb.20204 19750487
100 Zhao Y.-T. Wang X.-D. Shi W.-Y. Zhong X.-H. Anti-abortive effect of quercetin and bornyl acetate on macrophages and IL-10 in uterus of mice African Journal of Biotechnology 2010 10 43 8675 8682 2-s2.0-80051769443 10.5897/AJB11.939
101 Karampour N. S. Arzi A. Varzi H. N. Mohammadian B. Rezaei M. Quercetin preventive effects on theophylline-induced anomalies in rat embryo Jundishapur Journal of Natural Pharmaceutical Products 2014 9 3, e17834 2-s2.0-84905240713
102 Dogan Z. Elbe H. Taslidere E. Soysal H. Cetin A. Demirtas S. Effects of ciprofloxacin on fetal rat liver during pregnancy and protective effects of quercetin Biotechnic & Histochemistry 2017 92 7 481 486 2-s2.0-85028530871 10.1080/10520295.2017.1356469 28836867
103 Khaksary-Mahabady M. Ranjbar R. Najafzadeh-Varzi H. Mohammadian B. Gohari-Behbahani N. Protective effect of quercetin on histomorphometric changes in kidney of retinoid acid-treated rat fetuses International Journal of Morphology 2018 36 1 338 344 2-s2.0-85044574116 10.4067/S0717-95022018000100338
104 Toumi M. L. Merzoug S. Tahraoui A. Effects of quercetin on predator stress-related hematological and behavioural alterations in pregnant rats and their offspring Journal of Biosciences 2016 41 2 237 249 2-s2.0-84966697440 10.1007/s12038-016-9613-1 27240984
105 Huang J. J. Liu X. Wang X. Q. Yang L. H. Qi D. S. Yao R. Q. Effects of quercetin on the learning and memory ability of neonatal rats with hypoxic-ischemic brain damage Zhongguo Dang Dai Er Ke Za Zhi 2012 146 454 457
106 Liu W. Zhang M. Feng J. Fan A. Zhou Y. Xu Y. The influence of quercetin on maternal immunity, oxidative stress, and inflammation in mice with exposure of fine particulate matter during gestation International Journal of Environmental Research and Public Health 2017 14 592 1 16 10.3390/ijerph14060592
107 Braga C. P. Baptista R. d. Peixoto F. B. Effects of Quercetin Administration on the Pregnancy Outcome of Diabetic Rats Journal of Diabetes & Metabolism 2012 03 02 1 4 10.4172/2155-6156.1000180
108 Shahzad H. Giribabu N. Muniandy S. Salleh N. Quercetin induces morphological and proliferative changes of rat's uteri under estrogen and progesterone influences International Journal of Clinical and Experimental Pathology 2014 7 9 5484 5494 2-s2.0-84911488826 25337190
109 Xu L. Sun L. Lu L. Zhong X. Ma Y. Qin J. Effects of Quercetin on CYP450 and Cytokines in Aroclor 1254 Injured Endometrial Cells of the Pregnant Rats BioMed Research International 2014 2014 7 497508 10.1155/2014/497508
110 Lee M. Yun S. Lee H. Yang J. Quercetin Mitigates Inflammatory Responses Induced by Vascular Endothelial Growth Factor in Mouse Retinal Photoreceptor Cells through Suppression of Nuclear Factor Kappa B International Journal of Molecular Sciences 2017 18 11 p. 2497 10.3390/ijms18112497
111 Song W. Zhao X. Xu J. Zhang H. Quercetin inhibits angiogenesis–mediated human retinoblastoma growth by targeting vascular endothelial growth factor receptor Oncology Letters 2017 14 3 3343 3348 2-s2.0-85026305290 10.3892/ol.2017.6623 28927086
112 Li F. Bai Y. Zhao M. Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro Ophthalmic Research 2015 53 3 109 116 2-s2.0-84923077203 10.1159/000369824 25676100
113 Lee H. N. Shin S. A. Choo G. S. Anti-inflammatory effect of quercetin and galangin in LPS-stimulated RAW264.7 macrophages and DNCB-induced atopic dermatitis animal models International Journal of Molecular Medicine 2018 41 2 888 898 2-s2.0-85040467710 29207037
114 Endale M. Park S.-C. Kim S. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF- κ B-induced inflammatory mediators production in RAW 264.7 cells Immunobiology 2013 218 12 1452 1467 10.1016/j.imbio.2013.04.019 2-s2.0-84885930898 23735482
115 Sanchez M. Lodi F. Vera R. Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta Journal of Nutrition 2007 137 4 910 915 2-s2.0-34247147180 10.1093/jn/137.4.910 17374653
116 Romero M. Jiménez R. Sánchez M. Quercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKC Atherosclerosis 2009 202 1 58 67 10.1016/j.atherosclerosis.2008.03.007 2-s2.0-57649232223 18436224
117 Lee K. M. Hwang M. K. Lee D. E. Lee K. W. Lee H. J. Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells Journal of Agricultural and Food Chemistry 2010 58 9 5815 5820 10.1021/jf903698s 2-s2.0-77952203012 20377179
118 Yang D. Liu X. Liu M. Chi H. Liu J. Han H. Protective effects of quercetin and taraxasterol against H2O2-induced human umbilical vein endothelial cell injury in vitro Experimental and Therapeutic Medicine 2015 10 4 1253 1260 2-s2.0-84940526713 10.3892/etm.2015.2713 26622474
119 Kleemann R. Verschuren L. Morrison M. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models Atherosclerosis 2011 218 1 44 52 10.1016/j.atherosclerosis.2011.04.023 2-s2.0-80052273994 21601209
120 Crespo I. García-Mediavilla M. V. Gutiérrez B. Sánchez-Campos S. Tuñón M. J. González-Gallego J. A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells British Journal of Nutrition 2008 100 5 968 976 10.1017/s0007114508966083 2-s2.0-53649084494 18394220
121 Overman A. Chuang C.-C. McIntosh M. Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media International Journal of Obesity 2011 35 9 1165 1172 2-s2.0-80052703398 10.1038/ijo.2010.272 21224828
122 Kim H. P. Mani I. Iversen L. Ziboh V. A. Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs Prostaglandins, Leukotrienes and Essential Fatty Acids 1998 58 1 17 24 2-s2.0-0031962808 10.1016/S0952-3278(98)90125-9
123 Li Y. Yao J. Han C. Quercetin, inflammation and immunity Nutrients 2016 8 3, article 167 10.3390/nu8030167 2-s2.0-84961238197
124 Lim H. Hyun P. K. Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids Planta Medica 2007 73 12 1267 1274 2-s2.0-35548931247 10.1055/s-2007-990220 17886198
125 Guo W. Ding J. Zhang A. The inhibitory effect of quercetin on asymmetric dimethylarginine-induced apoptosis is mediated by the endoplasmic reticulum stress pathway in glomerular endothelial cells International Journal of Molecular Sciences 2014 15 1 484 503 10.3390/ijms15010484 2-s2.0-84891799143 24451129
126 Nabavi S. F. Nabavi S. M. Mirzaei M. Moghaddam A. H. Protective effect of quercetin against sodium fluoride induced oxidative stress in rat's heart Food & Function 2012 3 4 437 441 2-s2.0-84859364830 10.1039/c2fo10264a 22314573
127 González-Esquivel A. E. Charles-Niño C. L. Pacheco-Moisés F. P. Ortiz G. G. Jaramillo-Juárez F. Rincón-Sánchez A. R. Beneficial effects of quercetin on oxidative stress in liver and kidney induced by titanium dioxide (TiO Toxicology Mechanisms and Methods 2015 25 3 166 175 10.3109/15376516.2015.1006491 25578686
128 Kocahan S. Dogan Z. Erdemli E. Taskin E. Protective effect of quercetin against oxidative stress-induced toxicity associated with doxorubicin and cyclophosphamide in rat kidney and liver tissue Iranian Journal of Kidney Diseases 2017 11 2 124 131 2-s2.0-85014778238 28270644
129 Bayne A.-C. V. Sohal R. S. Effects of superoxide dismutase/catalase mimetics on life span and oxidative stress resistance in the housefly, Musca domestica Free Radical Biology & Medicine 2002 32 11 1229 1234 2-s2.0-0036591866 10.1016/S0891-5849(02)00849-3 12031907
130 He Y. Cao X. Liu X. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway Experimental Cell Research 2015 339 1 122 134 2-s2.0-84947063717 10.1016/j.yexcr.2015.10.013 26476374
131 Perez-Vizcaino F. Duarte J. Jimenez R. Santos-Buelga C. Osuna A. Antihypertensive effects of the flavonoid quercetin Pharmacological Reports 2009 61 1 67 75 2-s2.0-66949138823 10.1016/S1734-1140(09)70008-8 19307694
132 Haleagrahara N. Miranda-Hernandez S. Alim M. A. Hayes L. Bird G. Ketheesan N. Therapeutic effect of quercetin in collagen-induced arthritis Biomedicine & Pharmacotherapy 2017 90 38 46 2-s2.0-85015839465 10.1016/j.biopha.2017.03.026 28342364
133 Conquer J. A. Maiani G. Azzini E. Raguzzini A. Holub B. J. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects Journal of Nutrition 1998 128 3 593 597 2-s2.0-0031956125 10.1093/jn/128.3.593 9482769
134 Egert S. Bosy-Westphal A. Seiberl J. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study British Journal of Nutrition 2009 102 7 1065 1074 10.1017/S0007114509359127 2-s2.0-73749083955 19402938
135 Pfeuffer M. Auinger A. Bley U. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms Nutrition, Metabolism & Cardiovascular Diseases 2013 23 5 403 409 2-s2.0-84876813600 10.1016/j.numecd.2011.08.010 22118955
136 Zahedi M. Ghiasvand R. Feizi A. Asgari G. Darvish L. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial International Journal of Preventive Medicine 2013 4 7 777 785 2-s2.0-84883860974 24049596
137 Javadi F. Eghtesadi S. Ahmadzadeh A. The effect of quercetin on plasma oxidative status, C-reactive protein and blood pressure in women with rheumatoid arthritis International Journal of Preventive Medicine 2014 5 3 293 301 2-s2.0-84897823795 24829713
138 Loizzo M. R. Said A. Tundis R. Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae) Phytotherapy Research 2007 21 1 32 36 10.1002/ptr.2008 2-s2.0-33846640446 17072829
139 Bujold E. Roberge S. Lacasse Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis Obstetrics & Gynecology 2010 116 2 402 414 10.1097/AOG.0b013e3181e9322a 2-s2.0-77955147909 20664402
140 Bujold E. Morency A.-M. Roberge S. Lacasse Y. Forest J.-C. Giguère Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis Journal of Obstetrics and Gynaecology Canada 2009 31 9 818 826 2-s2.0-75349104991 10.1016/S1701-2163(16)34300-6 19941706
141 World Health Organization “WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia Geneva, 2011, ISBN 978 92 4 154833 5
142 Roberge S. Nicolaides K. Demers S. Hyett J. Chaillet N. Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis American Journal of Obstetrics & Gynecology 2017 216 2 110 120.e6 2-s2.0-85010901103 10.1016/j.ajog.2016.09.076 27640943
143 Villa P. M. Kajantie E. Räikkönen K. Aspirin in the prevention of pre-eclampsia in high-risk women: A randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials BJOG: An International Journal of Obstetrics & Gynaecology 2013 120 1 64 74 2-s2.0-84871187491 10.1111/j.1471-0528.2012.03493.x 23126307
144 Mone F. Mulcahy C. McParland P. BMJ Open 2018 8 7 p. e022056 10.1136/bmjopen-2018-022056
145 Manolescu B. Oprea E. Busu C. Cercasov C. Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway Biochimie 2009 91 11-12 1347 1358 2-s2.0-73049091140 10.1016/j.biochi.2009.08.005 19703512
146 Hikmah E. M. Widjiati P. L. Apium graveolens prevents itrauterine growth restriction via suppression of antiangiogenic factor production Traditional Medicine Journal 2018 23 2 135 141
147 Rahayu B. Baktiyani S. C. W. Nurdiana N. Theobroma cacao increases cells viability and reduces IL-6 and sVCAM-1 level in endothelial cells induced by plasma from preeclamptic patients Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 2016 6 1 42 46 2-s2.0-84961990510 10.1016/j.preghy.2016.01.001 26955771
148 Barokah L. Baktiyani S. C. W. Kalsum U. Protective effect of Theobroma cacao on nitric oxide and endothelin-1 level in endothelial cells induced by plasma from preeclamptic patients: In silico and in vitro studies European Journal of Integrative Medicine 2016 8 1 73 78 2-s2.0-84956598368 10.1016/j.eujim.2015.11.023
149 Ambarwati D. Fatmawati F. Nooryanto M. Santoso S. Windu Baktiyani S. C. Nurdiana N. Punica granatum fruit extract inhibits the production of pro-inflammatory cytokines and angiogenic factors of HUVEC cells induced by plasma from patients with pre-eclampsia Clinical Nutrition Experimental 2017 15 9 14 2-s2.0-85028977887 10.1016/j.yclnex.2017.06.001
150 Nasifah I. Soeharto S. Nooryanto M. Effects of anti-lipid peroxidation of Punica granatum fruit extract in endothelial cells induced by plasma of severe pre-eclamptic patients Journal of Ayurveda and Integrative Medicine 2017 8 4 215 217 2-s2.0-85040124160 10.1016/j.jaim.2017.02.003 28928008
151 Shi D.-D. Guo J.-J. Zhou L. Wang N. Epigallocatechin gallate enhances treatment efficacy of oral nifedipine against pregnancy-induced severe pre-eclampsia: A double-blind, randomized and placebo-controlled clinical study Journal of Clinical Pharmacy and Therapeutics 2018 43 1 21 25 2-s2.0-85040016505 10.1111/jcpt.12597 28726273
152 Hachul A. C. Boldarine V. T. Neto N. I. Effect of the consumption of green tea extract during pregnancy and lactation on metabolism of mothers and 28d-old offspring Scientific Reports 2018 8 1 1 7 10.1038/s41598-018-20174-x 29311619
153 Cai X. Fang Z. Dou J. Yu A. Zhai G. Bioavailability of quercetin: Problems and promises Current Medicinal Chemistry 2013 20 20 2572 2582 2-s2.0-84877998754 10.2174/09298673113209990120 23514412
154 Kasikci M. B. Bagdatlioglu N. Bioavailability of quercetin Current Research in Nutrition and Food Science 2016 4 2 146 151 2-s2.0-85016075202 10.12944/CRNFSJ.4.Special-Issue-October.20
155 Harwood M. Danielewska-Nikiel B. Borzelleca J. F. Flamm G. W. Williams G. M. Lines T. C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties Food and Chemical Toxicology 2007 45 11 2179 2205 2-s2.0-34548812546 10.1016/j.fct.2007.05.015 17698276
156 Walle T. Walle U. K. Halushka P. V. Carbon dioxide is the major metabolite of quercetin in humans Journal of Nutrition 2001 131 10 2648 2652 2-s2.0-0034795649 10.1093/jn/131.10.2648 11584085
157 Andres S. Pevny S. Ziegenhagen R. Safety aspects of the use of quercetin as a dietary supplement Molecular Nutrition Food Research 2018 62 1 10 1002
158 Murota K. Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism Archives of Biochemistry and Biophysics 2003 417 1 12 17 10.1016/S0003-9861(03)00284-4 2-s2.0-0043063961 12921774
159 Guo Y. Bruno R. S. Endogenous and exogenous mediators of quercetin bioavailability The Journal of Nutritional Biochemistry 2015 26 3 201 210 2-s2.0-84927664696 10.1016/j.jnutbio.2014.10.008 25468612
160 Zizkova P. Stefek M. Rackova L. Prnova M. Horakova L. Novel quercetin derivatives: from redox properties to promising treatment of oxidative stress related diseases Chemico-Biological Interactions 2017 265 36 46 10.1016/j.cbi.2017.01.019 2-s2.0-85012284032 28137512
161 Grande F. Parisi O. I. Mordocco R. A. Quercetin derivatives as novel antihypertensive agents: Synthesis and physiological characterization European Journal of Pharmaceutical Sciences 2016 82 161 170 2-s2.0-84949033474 10.1016/j.ejps.2015.11.021 26631584
162 Lesjak M. Beara I. Simin N. Antioxidant and anti-inflammatory activities of quercetin and its derivatives Journal of Functional Foods 2018 40 68 75 2-s2.0-85032794501 10.1016/j.jff.2017.10.047
163 Ávila-Gálvez M. Á. González-Sarrías A. Espín J. C. In vitro research on dietary polyphenols and health: a call of caution and a guide on how to proceed Journal of Agricultural and Food Chemistry 2018 66 30 7857 7858 10.1021/acs.jafc.8b03377 30024157
164 Chen C. Zhou J. Ji C. Quercetin: A potential drug to reverse multidrug resistance Life Sciences 2010 87 11-12 333 338 2-s2.0-77956414625 10.1016/j.lfs.2010.07.004 20637779
165 Chen Z. Huang C. Ma T. Reversal effect of quercetin on multidrug resistance via FZD7/ β -catenin pathway in hepatocellular carcinoma cells Phytomedicine 2018 43 37 45 2-s2.0-85044931326 10.1016/j.phymed.2018.03.040 29747752
166 IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Geneva. World Health Organization International Agency for Research on Cancer 1999 73 1 19 https://monographs.iarc.fr/iarc-monographs-on-the-evaluation-of-carcinogenic-risks-to-humans-48/
167 Andres S. Pevny S. Ziegenhagen R. Safety Aspects of the Use of Quercetin as a Dietary Supplement Molecular Nutrition & Food Research 2018 62 1 1 15 2-s2.0-85040358614
168 Shi Y. Williamson G. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: A randomised, double-blinded, placebo-controlled, cross-over trial British Journal of Nutrition 2016 115 5 800 806 2-s2.0-84958603928 10.1017/S0007114515005310 26785820
169 Jin F. Nieman D. C. Shanely R. A. Knab A. M. Austin M. D. Sha W. The variable plasma quercetin response to 12-week quercetin supplementation in humans European Journal of Clinical Nutrition 2010 64 7 692 697 2-s2.0-77955013180 10.1038/ejcn.2010.91 20517329
170 Russo M. Spagnuolo C. Tedesco I. Bilotto S. Russo G. L. The flavonoid quercetin in disease prevention and therapy: facts and fancies Biochemical Pharmacology 2012 83 1 6 15 10.1016/j.bcp.2011.08.010 2-s2.0-81855164783 21856292
171 Shoskes D. A. Zeitlin S. I. Shahed A. Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial Urology 1999 54 6 960 963 10.1016/S0090-4295(99)00358-1 2-s2.0-0033252747 10604689
172 FDA (U.S. Food and Drug Administration), Agency response letter GRAS notice no. GRN 000341 2010, https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm235935.htm.
173 Peluso I. Raguzzini A. Serafini M. Effect of flavonoids on circulating levels of TNF- α and IL-6 in humans: a systematic review and meta-analysis Molecular Nutrition & Food Research 2013 57 5 784 801 10.1002/mnfr.201200721 2-s2.0-84876444918 23471810
174 Peluso I. Palmery M. Flavonoids at the pharma-nutrition interface: Is a therapeutic index in demand? Biomedicine & Pharmacotherapy 2015 71 102 107 2-s2.0-84928943647 10.1016/j.biopha.2015.02.028 25960223
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.